Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Biotechnology market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Biotechnology market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Biotechnology market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Biotechnology products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Biotechnology products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Biotechnology market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Biotechnology development has been the leading industry trend of Biotechnology market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Biotechnology Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
DNA Sequencing,Nanobiotechnology,Tissue engineering and Regeneration,Fermentation,Cell Based Assay,PCR Technology,Chromatography Market,Others |
| By Application Outlook |
Health,Food & Agriculture,Natural Resources & Environment,Industrial Processing,Bioinformatics,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Johnson & Johnson Services, Inc.,F. Hoffmann-La Roche Ltd,Pfizer,Merck & Co.,Sanofi,AstraZeneca,Gilead,CELGENE CORPORATION,Biogen,Amgen, Inc,Abbott,Novo Nordisk A/S,Novartis AG,Lonza |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Johnson & Johnson Services
- Inc.
- F. Hoffmann-La Roche Ltd
- Pfizer
- Merck & Co.
- Sanofi
- AstraZeneca
- Gilead
- CELGENE CORPORATION
- Biogen
- Amgen
- Inc
- Abbott
- Novo Nordisk A/S
- Novartis AG
- Lonza
Biotechnology Market, By Type
- DNA Sequencing
- Nanobiotechnology
- Tissue engineering and Regeneration
- Fermentation
- Cell Based Assay
- PCR Technology
- Chromatography Market
- Others
Biotechnology Market, By Application
- Health
- Food & Agriculture
- Natural Resources & Environment
- Industrial Processing
- Bioinformatics
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Biotechnology Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Biotechnology Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 DNA Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Nanobiotechnology Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Tissue engineering and Regeneration Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Fermentation Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.5 Cell Based Assay Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.6 PCR Technology Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.7 Chromatography Market Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.8 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Biotechnology Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Biotechnology Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Biotechnology Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Biotechnology Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Biotechnology Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Biotechnology Market Assessment by Type
8.1 Asia Pacific Biotechnology Market Assessment by Application (Consumption and Market Share)
8.2 North America Biotechnology Market Assessment by Application (Consumption and Market Share)
8.3 Europe Biotechnology Market Assessment by Application (Consumption and Market Share)
8.4 South America Biotechnology Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Biotechnology Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Johnson & Johnson Services, Inc.
9.1.1 Johnson & Johnson Services, Inc. Profiles
9.1.2 Johnson & Johnson Services, Inc. Product Portfolio
9.1.3 Johnson & Johnson Services, Inc. Biotechnology Business Performance
9.1.4 Johnson & Johnson Services, Inc. Biotechnology Business Development and Market Status
9.2 F. Hoffmann-La Roche Ltd
9.2.1 F. Hoffmann-La Roche Ltd Profiles
9.2.2 F. Hoffmann-La Roche Ltd Product Portfolio
9.2.3 F. Hoffmann-La Roche Ltd Biotechnology Business Performance
9.2.4 F. Hoffmann-La Roche Ltd Biotechnology Business Development and Market Status
9.3 Pfizer
9.3.1 Pfizer Profiles
9.3.2 Pfizer Product Portfolio
9.3.3 Pfizer Biotechnology Business Performance
9.3.4 Pfizer Biotechnology Business Development and Market Status
9.4 Merck & Co.
9.4.1 Merck & Co. Profiles
9.4.2 Merck & Co. Product Portfolio
9.4.3 Merck & Co. Biotechnology Business Performance
9.4.4 Merck & Co. Biotechnology Business Development and Market Status
9.5 Sanofi
9.5.1 Sanofi Profiles
9.5.2 Sanofi Product Portfolio
9.5.3 Sanofi Biotechnology Business Performance
9.5.4 Sanofi Biotechnology Business Development and Market Status
9.6 AstraZeneca
9.6.1 AstraZeneca Profiles
9.6.2 AstraZeneca Product Portfolio
9.6.3 AstraZeneca Biotechnology Business Performance
9.6.4 AstraZeneca Biotechnology Business Development and Market Status
9.7 Gilead
9.7.1 Gilead Profiles
9.7.2 Gilead Product Portfolio
9.7.3 Gilead Biotechnology Business Performance
9.7.4 Gilead Biotechnology Business Development and Market Status
9.8 CELGENE CORPORATION
9.8.1 CELGENE CORPORATION Profiles
9.8.2 CELGENE CORPORATION Product Portfolio
9.8.3 CELGENE CORPORATION Biotechnology Business Performance
9.8.4 CELGENE CORPORATION Biotechnology Business Development and Market Status
9.9 Biogen
9.9.1 Biogen Profiles
9.9.2 Biogen Product Portfolio
9.9.3 Biogen Biotechnology Business Performance
9.9.4 Biogen Biotechnology Business Development and Market Status
9.10 Amgen, Inc
9.10.1 Amgen, Inc Profiles
9.10.2 Amgen, Inc Product Portfolio
9.10.3 Amgen, Inc Biotechnology Business Performance
9.10.4 Amgen, Inc Biotechnology Business Development and Market Status
9.11 Abbott
9.12 Novo Nordisk A/S
9.13 Novartis AG
9.14 Lonza
10 World Biotechnology Market Assessment by Players
10.1 Global Biotechnology Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Biotechnology Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Biotechnology Price (USD/Unit) of Players 2014-2020
10.4 Global Biotechnology Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Biotechnology Sales Assessment of Players 2014-2020
11.1.2 North America Biotechnology Revenue Assessment of Players 2014-2020
11.1.3 North America Biotechnology Price Assessment of Players 2014-2020
11.1.4 North America Biotechnology Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Biotechnology Sales Assessment of Players 2014-2020
11.2.2 Europe Biotechnology Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Biotechnology Price Assessment of Players 2014-2020
11.2.4 Europe Biotechnology Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Biotechnology Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Biotechnology Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Biotechnology Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Biotechnology Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Biotechnology Sales Assessment of Players 2014-2020
11.4.2 South America Biotechnology Revenue Assessment of Players 2014-2020
11.4.3 South America Biotechnology Price Assessment of Players 2014-2020
11.4.4 South America Biotechnology Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Biotechnology Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Biotechnology Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Biotechnology Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Biotechnology Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Biotechnology Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Biotechnology Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Biotechnology Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Biotechnology Sales by Countries/Regions 2014-2020
12.2.2 North America Biotechnology Revenue by Countries/Regions 2014-2020
12.2.3 North America Biotechnology Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Biotechnology Sales by Countries/Regions 2014-2020
12.3.2 Europe Biotechnology Revenue by Countries/Regions 2014-2020
12.3.3 Europe Biotechnology Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Biotechnology Sales by Countries/Regions 2014-2020
12.4.2 South America Biotechnology Revenue by Countries/Regions 2014-2020
12.4.3 South America Biotechnology Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Biotechnology Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Biotechnology Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Biotechnology Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Biotechnology Sales & Revenue Forecast 2021-2026
14.1 World Biotechnology Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World BiotechnologySales and Market Share by Regions
14.1.2 World BiotechnologyRevenue and Market Share by Regions
15 Asia Biotechnology Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 DNA Sequencing
15.1.2 Nanobiotechnology
15.1.3 Tissue engineering and Regeneration
15.1.4 Fermentation
15.1.5 Cell Based Assay
15.1.6 PCR Technology
15.1.7 Chromatography Market
15.1.8 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America Biotechnology Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 DNA Sequencing
16.1.2 Nanobiotechnology
16.1.3 Tissue engineering and Regeneration
16.1.4 Fermentation
16.1.5 Cell Based Assay
16.1.6 PCR Technology
16.1.7 Chromatography Market
16.1.8 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Biotechnology Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 DNA Sequencing
17.1.2 Nanobiotechnology
17.1.3 Tissue engineering and Regeneration
17.1.4 Fermentation
17.1.5 Cell Based Assay
17.1.6 PCR Technology
17.1.7 Chromatography Market
17.1.8 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America Biotechnology Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 DNA Sequencing
18.1.2 Nanobiotechnology
18.1.3 Tissue engineering and Regeneration
18.1.4 Fermentation
18.1.5 Cell Based Assay
18.1.6 PCR Technology
18.1.7 Chromatography Market
18.1.8 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Biotechnology Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 DNA Sequencing
19.1.2 Nanobiotechnology
19.1.3 Tissue engineering and Regeneration
19.1.4 Fermentation
19.1.5 Cell Based Assay
19.1.6 PCR Technology
19.1.7 Chromatography Market
19.1.8 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Biotechnology Price (USD/Unit) Trend 2021-2026
20.2 Global Biotechnology Gross Profit Trend 2021-2026
21 Conclusion
